VACCINEDAT JULIAN BENOIT IS YOUR AVG 11-YEAR-OLD 5TH GRADER LOVES SHOOTING HOOPS AND TRAMPOLINE TIME BUT IN AUGUST HE TESTED POSIVE WTIITH COVID 19 >> WE QUARANTINED HIMOR0 F DAYS. NO SYMPTOMS AND THEN WENT BACK TO SCHOOL, BUT A FEW WEEKSAT L REPOERRT: JULIAN GOT ANOTHER HEADACHE AND THIS ONE WAS MORE SEOUS >> JULIAN HAD A HEADACHE ANDY SATURDAY HE HAD A FEVER. BY SUNDAY 2:00 A.M., HEOU CLDN’T TELL US HIS LAST NAME. REPORTER: MIS-C IS MULTISYSMTE INFLAMMATORY SYNDROME POST COVID 3 IN 10,000 KIDS GET IT AFTER GETTING COD-VI >> WE UNDERSTOOD HOW TO TREATT I WITHOV. C REPORTER: DR KISTIN MOFFITT AT CHILDRENS HOSP KNOWS KIDS LIKE JULIAN WHO GOT MIS-C AFTER LITTLER NO SYMPTOMS THE FIST TIME AROUND WITH COVID AND IS A SUPPORTER OF PEDIATRIC VACCINES OF CIDOV 19. STJU LIKE JULIAN’S MOM >> WE DON’T WANT ANY OTHER FAMILIES TO GO THRU WHAT WWEE THROUGH. REPORTER: HAPPY TO REPORT JULIAN IS DOING FINE. HE HAS 2 YOUNGERIB SLINGS THA WILL BE VACCINATED THIS WEEK
Advertisement
Family urges vaccination, shares story of son’s experience with rare COVID-19 complication
Updated: 4:45 PM EST Nov 8, 2021
The family of a Massachusetts child who suffered a serious, rare health impact from COVID-19 wants to share their story in support of efforts to get kids vaccinated with the Pfizer’s shot that received the green light from federal health officials last week. “We don’t want any other families to go through what we went through,” Nia Benoit said.Her son, Julian, is an average 11-year-old. He’s in the fifth grade, loves shooting hoops and enjoys bouncing on his trampoline. Unfortunately, he caught COVID-19 in August.”We quarantined him for 10 days, and he really had no other symptoms, and then he was fine. He returned to school and returned to sports,” Benoit said.A few weeks later, Julian got a headache. It was very serious.”Julian had a headache on a Friday, so stayed home from school. And then, Saturday, he had a fever. And then, Saturday… Sunday at 2 a.m. he couldn’t tell us his last name and he couldn’t speak fluently,” Benoit said.He was rushed to Boston Children’s Hospital, where he spent six days in the intensive care unit and was eventually diagnosed with multisystem inflammatory syndrome post-COVID-19.Even though it’s rare, affecting three per 10,000 people under age 21 who are exposed to the virus, it may be more common in children ages 6 to 12.”We came to understand how to treat it but, clearly, being able to prevent cases of MIS-C by preventing COVID-19 infection through vaccination would be one really important reason to be able to vaccinate kids,” said Dr. Kristin Moffitt, an infectious disease specialist at Boston Children’s Hospital. In light of their experience, the Benoit family plans to vaccinate Julian’s younger siblings soon. Because of his diagnosis, Julian will have to wait 90 days before he can get his first dose.
The family of a Massachusetts child who suffered a serious, rare health impact from COVID-19 wants to share their story in support of efforts to get kids vaccinated with the Pfizer’s shot that received the green light from federal health officials last week.
“We don’t want any other families to go through what we went through,” Nia Benoit said.
Advertisement
Her son, Julian, is an average 11-year-old. He’s in the fifth grade, loves shooting hoops and enjoys bouncing on his trampoline. Unfortunately, he caught COVID-19 in August.
“We quarantined him for 10 days, and he really had no other symptoms, and then he was fine. He returned to school and returned to sports,” Benoit said.
A few weeks later, Julian got a headache. It was very serious.
“Julian had a headache on a Friday, so stayed home from school. And then, Saturday, he had a fever. And then, Saturday… Sunday at 2 a.m. he couldn’t tell us his last name and he couldn’t speak fluently,” Benoit said.
He was rushed to Boston Children’s Hospital, where he spent six days in the intensive care unit and was eventually diagnosed with multisystem inflammatory syndrome post-COVID-19.
Even though it’s rare, affecting three per 10,000 people under age 21 who are exposed to the virus, it may be more common in children ages 6 to 12.
“We came to understand how to treat it but, clearly, being able to prevent cases of MIS-C by preventing COVID-19 infection through vaccination would be one really important reason to be able to vaccinate kids,” said Dr. Kristin Moffitt, an infectious disease specialist at Boston Children’s Hospital.
In light of their experience, the Benoit family plans to vaccinate Julian’s younger siblings soon. Because of his diagnosis, Julian will have to wait 90 days before he can get his first dose.